EU and US regulators have now fully implemented the mutual recognition agreement (MRA) that allows them to rely on each other’s manufacturing inspection results for medicines in their own territories, after Slovakia became the final country to be cleared to join the initiative.
In addition, as of 11 July, a batch test waiver under the MRA also started to apply